This brand name is authorized in Lithuania, Poland, Romania
The drug IPERTROFAN contains one active pharmaceutical ingredient (API):
|
1
Mepartricin
UNII B7FBW3Y74G - MEPARTRICIN
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G04CX03 | Mepartricin | G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CX Other drugs used in benign prostatic hypertrophy |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1010062, 1010378, 1066904, 1078157 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100079406 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W04114002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
